Recently, the University of Oxford began an international study to examine the potential therapeutic benefits of cannabidiol (CBD) in treating psychosis or psychotic symptoms.
This study, which evaluated the potential of a well-designed unidirectional aseptic processing approach to both hydrocarbon and supercritical carbon dioxide extract manufacturing, suggests that the extraction process is capable of deactivating or removing the tested microbial contaminants when highly contaminated Cannabis spp. Inflorescence is used as feed material.
In this interview, Abbey Roudebush, Director of Government Affairs for Americans for Safe Access (ASA), explains the goals of ASA and provides an in-depth analysis of their annual State of the States report.
In this article, regulatory requirements are explored as they are meant to create confidence that cannabis and cannabis-infused products are safe to use.
The Cannabis Center of Excellence, Inc., Medicinal Genomics, and UMass Dartmouth have established the Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study to help better understand the experiences of healthcare providers have seen with medical cannabis.
In this interview, learn about Nicole DiMonda’s incredible story and Jaime Brambila ’s research efforts to document her case and help the lives of other cancer patients.
United Nations hold historic vote announcing cannabis's Schedule IV removal from the 1961 Single Convention on Narcotics.
The proceeds raised from the special Veterans Day webcast will help support the families of America's fallen military heroes.
Welcome to the first edition of Cannabis Patient Care!
A report on the findings from the anonymous 2019 Veterans Health and Medical Cannabis Study, which was a national and Massachusetts-focused research study led by Dr. Marion McNabb, Stephen Mandile, and Dr. Stephen White.
Stephen Mandile—veteran, cannabis patient, and advocate—shares his personal experience with medical cannabis and how it has given him a new mission to help other veterans gain access to this plant.
An in-depth conversation with Dr. Staci Gruber, Director of the Cognitive and Clinical Neuroimaging Core, Director of Marijuana Investigations for Neuroscientific Discovery (MIND) at McLean Hospital, and Associate Professor of Psychiatry at Harvard Medical School on her interest in medical cannabis and the medical cannabis research areas that MIND is focusing on for veterans and beyond.
Ann M. Brum and Wayne Smith discuss their roles as cannabis advocates fighting for reform and veteran access to medical cannabis.
Tracey Gregory, RN, discusses her experiences with veteran patients with PTSD, her work with Hospice for Heroes, medical cannabis, and more.
Jamie Pascua, a Veterans Affairs caregiver, shares her unique perspective on medical cannabis and her role caring for her disabled veteran spouse.
Dr. Junella Chin, the Founder of MedLeaf RX and the Chief Medical Advisor for Yesterday Wellness, discusses with us the beneficial aspects CBD and how the medical field is beginning to incorporate the concept of medical cannabis into patient treatments.
A review on a handful of recent articles related to COVID-19 and cannabis as well as an interview with a top medical cannabis expert—Dr. Prakash Nagarkatti.
An interview with Dr. Bonni Goldstein on treating patients during a pandemic, telemedicine, cannabis research, and more.
An interview with an amazing family of four doctors—the Knox Docs—who are key opinion leaders in cannabis therapeutics, endocannabinology, and cannabinoid medicine.
A tribute piece to Charlotte Figi, a medical cannabis and CBD pioneer who inspired the name of the medical cannabis strain Charlotte’s Web.
On Tuesday, December 3, 2019, Brazil’s pharmaceutical regulator Avinsa approved regulations for the roll-out of medicinal cannabis-based products.
A long history of cannabis discoveries and research has put Israel at the forefront of medical cannabis developments, worldwide collaborations, and investor activity.
A review of the literature to examine the analgesic properties of cannabis.
What changes need to be adopted in our industry to make the transition to the pharmaceutical industry testing paradigm?
